Zearalanol compounds are described and demonstrated or predicted to have utility as Heat Shock Protein 90 (HSP90) inhibiting agents in the treatment and prevention of various disorders. Methods of synthesis and use of such compounds are also described and claimed.

 
Web www.patentalert.com

< Aryl aniline .beta.2 adrenergic receptor agonists

> Apparatus and process for dose-guided radiotherapy

> X-ray fluorescence visualizing, imaging, or information providing of chemicals, compounds, or biological materials

~ 00530